Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 2,500.0%

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 2,600 shares, an increase of 2,500.0% from the October 15th total of 100 shares. Based on an average daily volume of 700 shares, the short-interest ratio is presently 3.7 days.

Oxford Biomedica Stock Up 6.1 %

Oxford Biomedica stock traded up $0.31 during mid-day trading on Thursday, reaching $5.41. The company’s stock had a trading volume of 4,750 shares, compared to its average volume of 6,415. Oxford Biomedica has a 12 month low of $2.09 and a 12 month high of $5.68. The business’s 50 day simple moving average is $4.96 and its 200 day simple moving average is $4.46. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.